Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial

Journal of the National Cancer Institute

Volumn 92, Issue 14, 2000, Pages 1143-1150

  Van Dongen, Joop A ^a   Voogd, Adri C ^c   Fentiman, Ian S ^d   Legrand, Catherine ^e   Sylvester, Richard J ^e   Tong, David ^d   Van Der Schueren, Emmanuel ^f   Helle, Peter A ^g   Van Zijl, Kobus ^h   Bartelink, Harry ^b,i  

^a Department of Surgery ^*  (Belgium)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c The Netherlands   (Netherlands)

^d GUY S HOSPITAL   (United Kingdom)

^e EORTC DATA CENTER   (Belgium)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h STELLENBOSCH UNIVERSITY   (South Africa)

ⁱ ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0034686622     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.14.1143     Document Type: Article

References (26)

1. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy
2. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast
3. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial
4. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
5. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
6. Results of the National Cancer Institute early breast cancer trial
7. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial
8. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis
9. Effects of radiotherapy and surgery in early breast cancer. An overview of randomized trials
10. Breast-conserving therapy vs mastectomy in early-stage breast cancer: A meta-analysis of 10-year survival
11. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer
12. Nonparametric estimation from incomplete observations
13. Regression models and life tables
14. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
15. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
16. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer
17. Significance of ipsilateral breast tumour recurrence after lumpectomy
18. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up
19. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis
20. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events
21. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence
22. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
23. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
24. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM)
25. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: Results of EORTC Trial 10801